Biodexa Pharmaceuticals American Depositary Shs Stock Forecast

Sell candidate since Jun 10, 2026 Loss -99.99%

The Biodexa Pharmaceuticals Plc American stock price gained 4.76% on the last trading day (Friday, 7th Aug 2026), rising from $1.47 to $1.54. During the last trading day the stock fluctuated 16.67% from a day low at $1.44 to a day high of $1.68. The price has been going up and down for this period, and there has been a -99.99% loss for the last 2 weeks. Volume fell on the last day by -13 thousand shares and in total, 24 thousand shares were bought and sold for approximately $36.95 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at -$2,685.50 is broken, it will firstly indicate a stronger fall rate. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.

BDRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, July 31, 2026, and so far it has risen 16.67%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Biodexa Pharmaceuticals Plc American stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $18,491.76. On a fall, the stock will find some support from the short-term average at $1.47. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Biodexa Pharmaceuticals Plc American stock

Biodexa Pharmaceuticals Plc American finds support from accumulated volume at $1.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.240 between high and low, or 16.67%. For the last week the stock has had daily average volatility of 17.01%.

Biodexa Pharmaceuticals Plc American is oversold on RSI14 (1). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BDRX) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect Biodexa Pharmaceuticals Plc American Depositary Shs to open at $1.55, and during the day (based on 14 day Average True Range), to move between $0 and $923.23, which gives a possible trading interval of +/-$1,843.37 (+/-923 225 951.00%) up or down from last closing price. If Biodexa Pharmaceuticals Plc American Depositary Shs takes out the full calculated possible swing range there will be an estimated 923 225 951.00% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.

Since the stock is closer to the resistance from accumulated volume at $1.59 (3.25%) than the support at $1.49 (3.25%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Biodexa Pharmaceuticals Plc American Depositary Shs stock A Buy?

Biodexa Pharmaceuticals Plc American holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.744 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $1.55 ( 0.87%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk